Results 201 to 205 of about 1,795 (205)
Some of the next articles are maybe not open access.
Safety and Tolerability of Odanacatib Therapy in Postmenopausal Women with Osteoporosis: Results from the Phase III Long-Term Odanacatib Fracture Trial (LOFT)
2014 Papapoulos, S, McClung, MR, Langdahl, B, Saag, KG, Adami, S, Bone, HG, de Villiers, T, Kiel, DP, Kung, A, Kumar, P, Lim, SK, Ling, X, Lippuner, K, Mautalen, C, Nakamura, T, Reginster, Jean-Yves, Reid, IR, Rodriguez-Portales, JA, Roux, C, Walliser, J, Watts, NB, Zanchetta, J, Zerbini, CA, Rybak-Feiglin, A, Cohn, D, DaSilva, CA, Le Bailly De Tilleghem, C, Santora, A, Scott, BB, Verbruggen, N, Leung, A, Lombardi, A, Gurner, D +32 moreopenaire +2 more sourcesParadoxical stimulation of bone resorption by the anti-osteoporosis drug – odanacatib.
2016 Pirapaharan, Dinisha Cyril, Delaissé, Jean-Marie, Panwar, Preety, Overgaard, Martin, Bergmann, M, Schmedes, Anne Vibeke, Madsen, Jonna Skov, Bromme, D, Søe, Kent +8 moreopenaire +1 more sourcePhase 3 Fracture Trial Of Odanacatib For Osteoporosis - Baseline Characteristics and Study Design
2013 Papapoulos, S., Bone, H., Dempster, D., Eisman, J., Greenspan, S., Mcclung, M., Nakamura, T., Shih, J., Leung, A., Santora, A., Verbruggen, N., Lombardi, A. +11 moreopenaire +2 more sourcesOdanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial (vol 26, pg 699, 2015)
2015 Bone, H.G., Dempster, D.W., Eisman, J.A., Greenspan, S.L., McClung, M.R., Nakamura, T., Papapoulos, S., Shih, W.J., Rybak-Feiglin, A., Santora, A.C., Verbruggen, N., Leung, A.T., Lombardi, A. +12 moreopenaire +1 more source
